Cardiovascular Business Articles
People with severe but stable ischemic heart disease (SIHD) don’t benefit any more from invasive CV procedures than they do from optimal medical therapy (OMT) and lifestyle changes alone, according to results from the highly anticipated ISCHEMIA trial.
Millions of Americans are unaware of common heart attack symptoms, according to researchers, including a subset of 13.5 million people who admit to not knowing a single symptom of MI.
The net clinical benefit (NCB) of anticoagulants like warfarin and apixaban slows over time in patients with atrial fibrillation, according to a Circulation: Cardiovascular Quality and Outcomes study, diminishing as people age and face competing risks of death.
A 61-year-old patient at the West Virginia University Heart and Vascular Institute is the first in the state to receive a successful heart transplant, WVU reported Nov. 10.
Both severe and moderate aortic stenosis (AS), when left untreated, were associated with poor long-term survival in a large-scale study of Australian heart patients.
Multiarterial coronary artery bypass grafting (CABG) was linked to lower rates of long-term mortality, reintervention and MI than single-arterial CABG in a recent study of heart patients, suggesting the multiarterial approach is underused in contemporary practice.
A study out of the University of Pennsylvania School of Nursing suggests that weight loss achieved through a combination of intensive behavioral therapy (IBT) and 3 milligrams of liraglutide daily results in optimal weight-related quality of life for patients struggling with obesity.
CMS has finalized a rule that states, come Jan. 1, it will begin paying for certain percutaneous coronary interventions (PCIs) performed at ambulatory surgical centers (ASCs) in the U.S.
High-performing cardiology programs set the standard for patient care with respect to quality, resource utilization and patient as well as physician satisfaction.
It’s been more than six weeks since Zantac and generic formulas of ranitidine were pulled from pharmacy shelves due to carcinogenic impurities, but physicians in Pittsburgh aren’t convinced the recalls are over.
Stay Up-To-Date on jobs and industry news.
Sign up for the CathLab.com newsletter today!